Article

Acylcarnitine Metabolomic Profiles Inform Clinically-Defined Major Depressive Phenotypes

2019-05-09

Abstract excerpt

<h4>Background</h4> Acylcarnitines have important functions in mitochondrial energetics and β-oxidation, and have been implicated to play a significant role in metabolic functions of the brain. This retrospective study examined whether plasma acylcarnitine profiles can help biochemically distinguish the three phenotypic subtypes of major depressive disorder (MDD)—(core depression (CD+), anxious depression (ANX+),...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: dcf09ad1-5681-59b9-8cfd-7c917b1db3fb
DOI: 10.1101/632448

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Acylcarnitine Metabolomic Profiles Inform Clinically-Defined Major Depressive PhenotypesDOI 10.1101/632448Read

Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypes.Semantic proximity Read

Acylcarnitines metabolism in depression: association with diagnostic status, depression severity and symptom profile in the NESDA cohortSemantic proximity Read

The Metabolome-Wide Signature of Major Depressive DisorderSemantic proximity Read

Peripheral Metabolic-Redox Signaling as a Core Mechanism of Major Depressive Disorder: Evidence From Deep Metabolomic PhenotypingSemantic proximity Read

Peripheral metabolic-redox signaling as a core mechanism of major depressive disorder: evidence from deep metabolomic phenotyping.Semantic proximity Read

Deep Lipidomic Phenotyping Identifies Ceramide-Centered Lipotoxicity and Depletion of Plasmalogen-Carnitine Pathways in Major Depressive Disorder: Implications for Precision MedicineSemantic proximity Read

Rare variants and biological pathways identified in treatment-refractory depression.Semantic proximity Read

Focus on fatty acids in the neurometabolic pathophysiology of psychiatric disordersSemantic proximity Read

Atypical depression is associated with a distinct clinical, neurobiological, treatment response and polygenic risk profileSemantic proximity Read

Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants.Semantic proximity Read

Transformations in Plasma Metabolic Profiles of Patients with Major Depression During Treatment: A Pilot Metabolomics StudySemantic proximity Read

Differential urinary metabolites related with the severity of major depressive disorder.Semantic proximity Read